Please provide your email address to receive an email when new articles are posted on . Nasal glucagon was noninferior to intramuscular glucagon for treating hypoglycemia in Japanese adults with type ...

Please provide your email address to receive an email when new articles are posted on . Insulin-induced hypoglycemia was effectively treated with intranasal glucagon in adults with type 1 diabetes, ...

HealthDay News — For patients with type 1 diabetes, intranasal glucagon is effective for treating insulin-induced hypoglycemia, according to a study published online December 17 in Diabetes Care.

BERLIN — An investigational nasal glucagon offers the potential for an easier-to-use alternative to the injected version of the hypoglycemia rescue medication, new data suggest. Findings from a ...

The Food and Drug Administration (FDA) has approved Baqsimi (glucagon; Eli Lilly) nasal powder for the treatment of severe hypoglycemia in patients with diabetes aged 4 years and older. The Food and ...

Overview: Glucagon is commonly used to increase blood sugar levels in people with dangerously low levels. It can also be used during certain tests to slow down gut movement. Common side effects may ...

HealthDay News — For patients with type 1 diabetes, intranasal glucagon is effective for treating insulin-induced hypoglycemia, according to a study published online Dec. 17 in Diabetes Care. Michael ...

An investigational intranasal glucagon product may treat hypoglycemia just as effectively as intramuscular injections, a new study of adults with type 1 diabetes suggests. The intranasal glucagon ...